Latiglutenase Improves Symptoms in Seropositive Celiac Disease Patients While on a Gluten-Free Diet

被引：0
作者：
Jack A. Syage
Joseph A. Murray
Peter H. R. Green
Chaitan Khosla
机构：
[1] ImmunogenX,Division of Gastroenterology and Hepatology
[2] Mayo Clinic,Departments of Chemical Engineering and Chemistry
[3] Celiac Disease Center at Columbia University,undefined
[4] Stanford University,undefined
来源：
Digestive Diseases and Sciences | 2017年 / 62卷
关键词：
Celiac disease; Latiglutenase; Therapy; Symptoms;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：2428 / 2432
页数：4
相关论文
共 59 条
[11]  
Sanders DS(2016)Development of celiac disease therapeutics: report of the third gastroenterology regulatory endpoints and advancement of therapeutics workshop Gastroenterology 151 407-411
[12]  
Gottlieb K(2017)A novel patient-derived conceptual model of the impact of celiac disease in adults: implications for patient-reported outcome and hela-related quality-of-life instrument development Value Health 5 445-450
[13]  
Dawson J(2016)Disease activity indices in coeliac disease: systematic review and recommendations for clinical trials Gut 97 2016-2021
[14]  
Hussain F(2007)Etiologies and predictors of diagnosis in nonresponsive celiac disease Clin Gastroenterol Hepatol 39 26-29
[15]  
Murray JA(2002)Etiology of nonresponsive celiac disease: results of a systematic approach Am J Gastroenterol undefined undefined-undefined
[16]  
Lahdeaho ML(2007)Lack of correlation of degree of villous atrophy with severity of clinical presentation of coeliac disease Dig Liver Dis undefined undefined-undefined
[17]  
Kaukinen K(undefined)undefined undefined undefined undefined-undefined
[18]  
Laurila K(undefined)undefined undefined undefined undefined-undefined
[19]  
Wolf C(undefined)undefined undefined undefined undefined-undefined
[20]  
Siegel JB(undefined)undefined undefined undefined undefined-undefined
123456